Paramita M Ghosh

Title(s)Professor, Urology
SchoolSchool of Medicine
Address4860 Y Street, Suite 3500
CA 95817
Phone916-734-7805
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    (PQD-1) Selective pressure of antiandrogens on castration resistant prostate canc
    NIH/NCI R01CA185509Jul 18, 2014 - May 31, 2018
    Role: Principal Investigator
    Loss of Filamin A Nuclear Localization in Prostate Cancer Progression
    VA I01BX000400Apr 1, 2009 - Jun 30, 2019
    Role: Principal Investigator
    Rapamycin Regulation of the Androgen Receptor: Implications in Prostate Cancer
    NIH/NCI R01CA133209Mar 13, 2009 - Dec 31, 2014
    Role: Principal Investigator
    Role of HER3 in androgen-independent prostate cancer
    NIH/NCI R21CA109057Sep 7, 2005 - Aug 31, 2008
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Clinicopathologic Characterization of Prostatic Cancer in Dogs. Animals (Basel). 2024 Feb 10; 14(4). Vasilatis DM, Ghosh PM. PMID: 38396556.
      View in: PubMed   Mentions:
    2. Transcriptional-translational conflict: a novel exploitable tumor suppressive mechanism. Signal Transduct Target Ther. 2023 09 25; 8(1):361. Mudryj M, Ghosh PM. PMID: 37743426; PMCID: PMC10518313.
      View in: PubMed   Mentions:    Fields:    
    3. Beyond Prostate Cancer: An Androgen Receptor Splice Variant Expression in Multiple Malignancies, Non-Cancer Pathologies, and Development. Biomedicines. 2023 Aug 07; 11(8). Katleba KD, Ghosh PM, Mudryj M. PMID: 37626712; PMCID: PMC10452427.
      View in: PubMed   Mentions: 1  
    4. Prostate cancer and bone: clinical presentation and molecular mechanisms. Endocr Relat Cancer. 2023 09 01; 30(9). Wells KV, Krackeler ML, Jathal MK, Parikh M, Ghosh PM, Leach JK, Genetos DC. PMID: 37226936; PMCID: PMC10696925.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    5. Pesticides and Bladder Cancer: Mechanisms Leading to Anti-Cancer Drug Chemoresistance and New Chemosensitization Strategies. Int J Mol Sci. 2023 Jul 13; 24(14). Lucchesi CA, Vasilatis DM, Mantrala S, Chandrasekar T, Mudryj M, Ghosh PM. PMID: 37511154; PMCID: PMC10380322.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    6. Androgen receptor transcriptional activity is required for heregulin-1β-mediated nuclear localization of the HER3/ErbB3 receptor tyrosine kinase. J Biol Chem. 2023 08; 299(8):104973. Jathal MK, Siddiqui S, Vasilatis DM, Durbin Johnson BP, Drake C, Mooso BA, D'Abronzo LS, Batra N, Mudryj M, Ghosh PM. PMID: 37380074; PMCID: PMC10407237.
      View in: PubMed   Mentions: 1     Fields:    
    7. Cisplatin-induced increase in heregulin 1 and its attenuation by the monoclonal ErbB3 antibody seribantumab in bladder cancer. Sci Rep. 2023 06 14; 13(1):9617. Steele TM, Tsamouri MM, Siddiqui S, Lucchesi CA, Vasilatis D, Mooso BA, Durbin-Johnson BP, Ma AH, Hejazi N, Parikh M, Mudryj M, Pan CX, Ghosh PM. PMID: 37316561; PMCID: PMC10267166.
      View in: PubMed   Mentions:    Fields:    
    8. The dynamic microenvironment associated with metastatic bone disease: Current concepts. J Surg Oncol. 2023 Sep; 128(3):468-477. Bhale R, Ghosh P, Theriault R, Thorpe S, Loots G, Randall RL. PMID: 37226887.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    9. Molecular Similarities and Differences between Canine Prostate Cancer and Human Prostate Cancer Variants. Biomedicines. 2023 Apr 05; 11(4). Vasilatis DM, Lucchesi CA, Ghosh PM. PMID: 37189720; PMCID: PMC10136260.
      View in: PubMed   Mentions:
    10. Androgen receptor-dependent regulation of metabolism in high grade bladder cancer cells. Sci Rep. 2023 01 31; 13(1):1762. Katleba KD, Tsamouri MM, Jathal M, Baek HB, Armenta RB, Tepper CG, Cortopassi G, Ghosh PM, Mudryj M. PMID: 36720985; PMCID: PMC9889754.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    11. Activation of neural lineage networks and ARHGEF2 in enzalutamide-resistant and neuroendocrine prostate cancer and association with patient outcomes. Commun Med (Lond). 2022; 2:118. Ning S, Zhao J, Lombard AP, D'Abronzo LS, Leslie AR, Sharifi M, Lou W, Liu C, Yang JC, Evans CP, Corey E, Chen HW, Yu A, Ghosh PM, Gao AC. PMID: 36159187; PMCID: PMC9492734.
      View in: PubMed   Mentions: 2  
    12. Exploring the therapeutic potential of Neem (Azadirachta Indica) for the treatment of prostate cancer: a literature review. Ann Transl Med. 2022 Jul; 10(13):754. Batra N, Kumar VE, Nambiar R, De Souza C, Yuen A, Le U, Verma R, Ghosh PM, Vinall RL. PMID: 35957716; PMCID: PMC9358515.
      View in: PubMed   Mentions: 1  
    13. Neuropilin-2 regulates androgen-receptor transcriptional activity in advanced prostate cancer. Oncogene. 2022 07; 41(30):3747-3760. Dutta S, Polavaram NS, Islam R, Bhattacharya S, Bodas S, Mayr T, Roy S, Albala SAY, Toma MI, Darehshouri A, Borkowetz A, Conrad S, Fuessel S, Wirth M, Baretton GB, Hofbauer LC, Ghosh P, Pienta KJ, Klinkebiel DL, Batra SK, Muders MH, Datta K. PMID: 35754042; PMCID: PMC9979947.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    14. Untargeted Metabolomics Identify a Panel of Urinary Biomarkers for the Diagnosis of Urothelial Carcinoma of the Bladder, as Compared to Urolithiasis with or without Urinary Tract Infection in Dogs. Metabolites. 2022 Feb 24; 12(3). Tsamouri MM, Durbin-Johnson BP, Culp WTN, Palm CA, Parikh M, Kent MS, Ghosh PM. PMID: 35323643; PMCID: PMC8951005.
      View in: PubMed   Mentions: 1  
    15. Comparative Cancer Cell Signaling in Muscle-Invasive Urothelial Carcinoma of the Bladder in Dogs and Humans. Biomedicines. 2021 Oct 14; 9(10). Tsamouri MM, Steele TM, Mudryj M, Kent MS, Ghosh PM. PMID: 34680588; PMCID: PMC8533305.
      View in: PubMed   Mentions: 5  
    16. Androgen Receptor-Mediated Nuclear Transport of NRDP1 in Prostate Cancer Cells Is Associated with Worse Patient Outcomes. Cancers (Basel). 2021 Sep 02; 13(17). Steele T, Sam A, Evans S, Browning E, Krig S, Macias K, Konda A, Siddiqui S, Durbin-Johnson B, Ghosh P, Vinall R. PMID: 34503235; PMCID: PMC8430998.
      View in: PubMed   Mentions:
    17. Celebrating the 80th anniversary of hormone ablation for prostate cancer. Endocr Relat Cancer. 2021 07 15; 28(8):T1-T10. Zoubeidi A, Ghosh PM. PMID: 34187942.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimals
    18. Depletion of androgen receptor low molecular weight isoform reduces bladder tumor cell viability and induces apoptosis. Cancer Lett. 2021 04 28; 504:49-57. Katleba K, Lombard AP, Tsamouri MM, Baek HB, Nishida KS, Libertini SJ, Platero AJ, Ma AH, Pan CX, Ghosh PM, Mudryj M. PMID: 33549708; PMCID: PMC7943249.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    19. The Androgen Receptor in Prostate Cancer: Effect of Structure, Ligands and Spliced Variants on Therapy. Biomedicines. 2020 Oct 15; 8(10). Messner EA, Steele TM, Tsamouri MM, Hejazi N, Gao AC, Mudryj M, Ghosh PM. PMID: 33076388; PMCID: PMC7602609.
      View in: PubMed   Mentions: 30  
    20. Genistein Combined Polysaccharide (GCP) Can Inhibit Intracrine Androgen Synthesis in Prostate Cancer Cells. Biomedicines. 2020 Aug 11; 8(8). Batra N, Sam A, Woldemariam T, Talbott G, de Vere White RW, Ghosh PM, Gaikwad NW, Kotchoni SO, Vinall RL. PMID: 32796613; PMCID: PMC7460199.
      View in: PubMed   Mentions: 3  
    21. The p14ARF tumor suppressor restrains androgen receptor activity and prevents apoptosis in prostate cancer cells. Cancer Lett. 2020 07 28; 483:12-21. Siddiqui S, Libertini SJ, Lucas CA, Lombard AP, Baek HB, Nakagawa RM, Nishida KS, Steele TM, Melgoza FU, Borowsky AD, Durbin-Johnson BP, Qi L, Ghosh PM, Mudryj M. PMID: 32330514; PMCID: PMC8034238.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimalsCells
    22. Non-circadian aspects of BHLHE40 cellular function in cancer. Genes Cancer. 2020; 11(1-2):1-19. Kiss Z, Mudryj M, Ghosh PM. PMID: 32577154; PMCID: PMC7289903.
      View in: PubMed   Mentions: 16  
    23. Galectin-1 inhibition induces cell apoptosis through dual suppression of CXCR4 and Ras pathways in human malignant peripheral nerve sheath tumors. Neuro Oncol. 2019 11 04; 21(11):1389-1400. Shih TC, Fan Y, Kiss S, Li X, Deng XN, Liu R, Chen XJ, Carney R, Chen A, Ghosh PM, Lam KS. PMID: 31127849; PMCID: PMC6827838.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimalsCells
    24. Methionine Adenosyltransferase 1a (MAT1A) Enhances Cell Survival During Chemotherapy Treatment and is Associated with Drug Resistance in Bladder Cancer PDX Mice. Int J Mol Sci. 2019 Oct 09; 20(20). Martin KA, Hum NR, Sebastian A, He W, Siddiqui S, Ghosh PM, Pan CX, de Vere White R, Loots GG. PMID: 31600961; PMCID: PMC6829260.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimalsCells
    25. Dacomitinib, but not lapatinib, suppressed progression in castration-resistant prostate cancer models by preventing HER2 increase. Br J Cancer. 2019 07; 121(3):237-248. Jathal MK, Steele TM, Siddiqui S, Mooso BA, D'Abronzo LS, Drake CM, Whang YE, Ghosh PM. PMID: 31209328; PMCID: PMC6738116.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimalsCells
    26. Overexpressed ABCB1 Induces Olaparib-Taxane Cross-Resistance in Advanced Prostate Cancer. Transl Oncol. 2019 Jul; 12(7):871-878. Lombard AP, Liu C, Armstrong CM, D'Abronzo LS, Lou W, Chen H, Dall'Era M, Ghosh PM, Evans CP, Gao AC. PMID: 31075528; PMCID: PMC6510951.
      View in: PubMed   Mentions: 9  
    27. Obatoclax, a BH3 Mimetic, Enhances Cisplatin-Induced Apoptosis and Decreases the Clonogenicity of Muscle Invasive Bladder Cancer Cells via Mechanisms That Involve the Inhibition of Pro-Survival Molecules as Well as Cell Cycle Regulators. Int J Mol Sci. 2019 Mar 14; 20(6). Steele TM, Talbott GC, Sam A, Tepper CG, Ghosh PM, Vinall RL. PMID: 30875757; PMCID: PMC6470498.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    28. XPO1 inhibition by selinexor induces potent cytotoxicity against high grade bladder malignancies. Oncotarget. 2018 Oct 02; 9(77):34567-34581. Baek HB, Lombard AP, Libertini SJ, Fernandez-Rubio A, Vinall R, Gandour-Edwards R, Nakagawa R, Vidallo K, Nishida K, Siddiqui S, Wettersten H, Landesman Y, Weiss RH, Ghosh PM, Mudryj M. PMID: 30349650; PMCID: PMC6195388.
      View in: PubMed   Mentions: 12     Fields:    
    29. Supra-physiological concentration of glyoxylate inhibits proliferation of human colon cancer cells through oxidative stress. Life Sci. 2018 Aug 15; 207:80-89. Patra T, Ghosh P, Alam N, Murmu N. PMID: 29852189.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    30. eIF4E Phosphorylation in Prostate Cancer. Neoplasia. 2018 06; 20(6):563-573. D'Abronzo LS, Ghosh PM. PMID: 29730477; PMCID: PMC5994774.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCells
    31. Targeting Galectin-1 Impairs Castration-Resistant Prostate Cancer Progression and Invasion. Clin Cancer Res. 2018 09 01; 24(17):4319-4331. Shih TC, Liu R, Wu CT, Li X, Xiao W, Deng X, Kiss S, Wang T, Chen XJ, Carney R, Kung HJ, Duan Y, Ghosh PM, Lam KS. PMID: 29666302; PMCID: PMC6125207.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansAnimalsCells
    32. Evaluation of Protein Levels of the Receptor Tyrosine Kinase ErbB3 in Serum. Methods Mol Biol. 2018; 1655:319-334. D'Abronzo LS, Pan CX, Ghosh PM. PMID: 28889394; PMCID: PMC6481935.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    33. Altered expression of hepatic β-adrenergic receptors in aging rats: implications for age-related metabolic dysfunction in liver. Am J Physiol Regul Integr Comp Physiol. 2018 04 01; 314(4):R574-R583. Shi Y, Shu ZJ, Wang H, Barnes JL, Yeh CK, Ghosh PM, Katz MS, Kamat A. PMID: 29212811; PMCID: PMC6712558.
      View in: PubMed   Mentions: 7     Fields:    Translation:AnimalsCells
    34. MicroRNA profiling of dogs with transitional cell carcinoma of the bladder using blood and urine samples. BMC Vet Res. 2017 Nov 15; 13(1):339. Kent MS, Zwingenberger A, Westropp JL, Barrett LE, Durbin-Johnson BP, Ghosh P, Vinall RL. PMID: 29141625; PMCID: PMC5688639.
      View in: PubMed   Mentions: 13     Fields:    Translation:Animals
    35. The androgen receptor is a negative regulator of eIF4E phosphorylation at S209: implications for the use of mTOR inhibitors in advanced prostate cancer. Oncogene. 2017 11 16; 36(46):6359-6373. D'Abronzo LS, Bose S, Crapuchettes ME, Beggs RE, Vinall RL, Tepper CG, Siddiqui S, Mudryj M, Melgoza FU, Durbin-Johnson BP, deVere White RW, Ghosh PM. PMID: 28745319; PMCID: PMC5690844.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansAnimalsCells
    36. A Novel Galectin-1 Inhibitor Discovered through One-Bead Two-Compound Library Potentiates the Antitumor Effects of Paclitaxel in vivo. Mol Cancer Ther. 2017 07; 16(7):1212-1223. Shih TC, Liu R, Fung G, Bhardwaj G, Ghosh PM, Lam KS. PMID: 28396365; PMCID: PMC5516795.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansAnimalsCells
    37. WOMEN IN CANCER THEMATIC REVIEW: Circadian rhythmicity and the influence of 'clock' genes on prostate cancer. Endocr Relat Cancer. 2016 11; 23(11):T123-T134. Kiss Z, Ghosh PM. PMID: 27660402; PMCID: PMC5148656.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimals
    38. WOMEN IN CANCER PROFILE: From physics to cancer biology and everywhere in between. Endocr Relat Cancer. 2016 11; 23(11):P15-P21. Ghosh PM. PMID: 27605444.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    39. A phase 2 clinical trial of everolimus plus bicalutamide for castration-resistant prostate cancer. Cancer. 2016 06 15; 122(12):1897-904. Chow H, Ghosh PM, deVere White R, Evans CP, Dall'Era MA, Yap SA, Li Y, Beckett LA, Lara PN, Pan CX. PMID: 27019001; PMCID: PMC4892938.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansCTClinical Trials
    40. Decreased expression of let-7c is associated with non-response of muscle-invasive bladder cancer patients to neoadjuvant chemotherapy. Genes Cancer. 2016 Mar; 7(3-4):86-97. Vinall RL, Tepper CG, Ripoll AA, Gandour-Edwards RF, Durbin-Johnson BP, Yap SA, Ghosh PM, deVere White RW. PMID: 27382433; PMCID: PMC4918947.
      View in: PubMed   Mentions: 11  
    41. Development and Characterization of Bladder Cancer Patient-Derived Xenografts for Molecularly Guided Targeted Therapy. PLoS One. 2015; 10(8):e0134346. Pan CX, Zhang H, Tepper CG, Lin TY, Davis RR, Keck J, Ghosh PM, Gill P, Airhart S, Bult C, Gandara DR, Liu E, de Vere White RW. PMID: 26270481; PMCID: PMC4535951.
      View in: PubMed   Mentions: 48     Fields:    Translation:HumansAnimalsCellsCTClinical Trials
    42. Disruptive environmental chemicals and cellular mechanisms that confer resistance to cell death. Carcinogenesis. 2015 Jun; 36 Suppl 1:S89-110. Narayanan KB, Ali M, Barclay BJ, Cheng QS, D'Abronzo L, Dornetshuber-Fleiss R, Ghosh PM, Gonzalez Guzman MJ, Lee TJ, Leung PS, Li L, Luanpitpong S, Ratovitski E, Rojanasakul Y, Romano MF, Romano S, Sinha RK, Yedjou C, Al-Mulla F, Al-Temaimi R, Amedei A, Brown DG, Ryan EP, Colacci A, Hamid RA, Mondello C, Raju J, Salem HK, Woodrick J, Scovassi AI, Singh N, Vaccari M, Roy R, Forte S, Memeo L, Kim SY, Bisson WH, Lowe L, Park HH. PMID: 26106145; PMCID: PMC4565614.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimalsPHPublic Health
    43. Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: the challenge ahead. Carcinogenesis. 2015 Jun; 36 Suppl 1:S254-96. Goodson WH, Lowe L, Carpenter DO, Gilbertson M, Manaf Ali A, Lopez de Cerain Salsamendi A, Lasfar A, Carnero A, Azqueta A, Amedei A, Charles AK, Collins AR, Ward A, Salzberg AC, Colacci A, Olsen AK, Berg A, Barclay BJ, Zhou BP, Blanco-Aparicio C, Baglole CJ, Dong C, Mondello C, Hsu CW, Naus CC, Yedjou C, Curran CS, Laird DW, Koch DC, Carlin DJ, Felsher DW, Roy D, Brown DG, Ratovitski E, Ryan EP, Corsini E, Rojas E, Moon EY, Laconi E, Marongiu F, Al-Mulla F, Chiaradonna F, Darroudi F, Martin FL, Van Schooten FJ, Goldberg GS, Wagemaker G, Nangami GN, Calaf GM, Williams G, Wolf GT, Koppen G, Brunborg G, Lyerly HK, Krishnan H, Ab Hamid H, Yasaei H, Sone H, Kondoh H, Salem HK, Hsu HY, Park HH, Koturbash I, Miousse IR, Scovassi AI, Klaunig JE, Vondrácek J, Raju J, Roman J, Wise JP, Whitfield JR, Woodrick J, Christopher JA, Ochieng J, Martinez-Leal JF, Weisz J, Kravchenko J, Sun J, Prudhomme KR, Narayanan KB, Cohen-Solal KA, Moorwood K, Gonzalez L, Soucek L, Jian L, D'Abronzo LS, Lin LT, Li L, Gulliver L, McCawley LJ, Memeo L, Vermeulen L, Leyns L, Zhang L, Valverde M, Khatami M, Romano MF, Chapellier M, Williams MA, Wade M, Manjili MH, Lleonart ME, Xia M, Gonzalez MJ, Karamouzis MV, Kirsch-Volders M, Vaccari M, Kuemmerle NB, Singh N, Cruickshanks N, Kleinstreuer N, van Larebeke N, Ahmed N, Ogunkua O, Krishnakumar PK, Vadgama P, Marignani PA, Ghosh PM, Ostrosky-Wegman P, Thompson PA, Dent P, Heneberg P, Darbre P, Sing Leung P, Nangia-Makker P, Cheng QS, Robey RB, Al-Temaimi R, Roy R, Andrade-Vieira R, Sinha RK, Mehta R, Vento R, Di Fiore R, Ponce-Cusi R, Dornetshuber-Fleiss R, Nahta R, Castellino RC, Palorini R, Abd Hamid R, Langie SA, Eltom SE, Brooks SA, Ryeom S, Wise SS, Bay SN, Harris SA, Papagerakis S, Romano S, Pavanello S, Eriksson S, Forte S, Casey SC, Luanpitpong S, Lee TJ, Otsuki T, Chen T, Massfelder T, Sanderson T, Guarnieri T, Hultman T, Dormoy V, Odero-Marah V, Sabbisetti V, Maguer-Satta V, Rathmell WK, Engström W, Decker WK, Bisson WH, Rojanasakul Y, Luqmani Y, Chen Z, Hu Z. PMID: 26106142; PMCID: PMC4480130.
      View in: PubMed   Mentions: 85     Fields:    Translation:HumansAnimalsPHPublic Health
    44. miR-148a dependent apoptosis of bladder cancer cells is mediated in part by the epigenetic modifier DNMT1. Mol Carcinog. 2016 May; 55(5):757-67. Lombard AP, Mooso BA, Libertini SJ, Lim RM, Nakagawa RM, Vidallo KD, Costanzo NC, Ghosh PM, Mudryj M. PMID: 25865490; PMCID: PMC4600638.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    45. Transcription of Nrdp1 by the androgen receptor is regulated by nuclear filamin A in prostate cancer. Endocr Relat Cancer. 2015 Jun; 22(3):369-86. Savoy RM, Chen L, Siddiqui S, Melgoza FU, Durbin-Johnson B, Drake C, Jathal MK, Bose S, Steele TM, Mooso BA, D'Abronzo LS, Fry WH, Carraway KL, Mudryj M, Ghosh PM. PMID: 25759396; PMCID: PMC4433410.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimalsCells
    46. Zoledronic acid at the time of castration prevented castration-induced bone metastasis in mice. Endocr Relat Cancer. 2014 Oct; 21(5):C11-4. Ghosh PM, Gao AC. PMID: 25183429.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    47. The role of EGFR family inhibitors in muscle invasive bladder cancer: a review of clinical data and molecular evidence. J Urol. 2015 Jan; 193(1):19-29. Mooso BA, Vinall RL, Mudryj M, Yap SA, deVere White RW, Ghosh PM. PMID: 25158272; PMCID: PMC4405894.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansCells
    48. The dual role of filamin A in cancer: can't live with (too much of) it, can't live without it. Endocr Relat Cancer. 2013 Dec; 20(6):R341-56. Savoy RM, Ghosh PM. PMID: 24108109; PMCID: PMC4376317.
      View in: PubMed   Mentions: 84     Fields:    Translation:HumansAnimalsCells
    49. Editorial comment. J Urol. 2013 Nov; 190(5):1697. Ghosh PM. PMID: 23933461.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    50. The changing roles of steroid nuclear receptors with prostate cancer progression. Endocr Relat Cancer. 2013 Aug; 20(4):C9-11. Savoy RM, Ghosh PM. PMID: 23744763.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    51. Linking inflammation and neuroendocrine differentiation: the role of macrophage migration inhibitory factor-mediated signaling in prostate cancer. Endocr Relat Cancer. 2013 Jun; 20(3):C1-4. Savoy RM, Ghosh PM. PMID: 23612613.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    52. Enhancing the effectiveness of androgen deprivation in prostate cancer by inducing Filamin A nuclear localization. Endocr Relat Cancer. 2012 Dec; 19(6):759-77. Mooso BA, Vinall RL, Tepper CG, Savoy RM, Cheung JP, Singh S, Siddiqui S, Wang Y, Bedolla RG, Martinez A, Mudryj M, Kung HJ, Devere White RW, Ghosh PM. PMID: 22993077; PMCID: PMC3540117.
      View in: PubMed   Mentions: 24     Fields:    Translation:AnimalsCells
    53. Role of β-adrenergic receptors in regulation of hepatic fat accumulation during aging. J Endocrinol. 2012 Jun; 213(3):251-61. Ghosh PM, Shu ZJ, Zhu B, Lu Z, Ikeno Y, Barnes JL, Yeh CK, Zhang BX, Katz MS, Kamat A. PMID: 22457517; PMCID: PMC3539306.
      View in: PubMed   Mentions: 22     Fields:    Translation:AnimalsCells
    54. What controls PTEN and what it controls (in prostate cancer). Asian J Androl. 2012 Jan; 14(1):130-1. Ghosh PM. PMID: 21946231; PMCID: PMC3539299.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    55. Dual EGFR/HER2 inhibition sensitizes prostate cancer cells to androgen withdrawal by suppressing ErbB3. Clin Cancer Res. 2011 Oct 01; 17(19):6218-28. Chen L, Mooso BA, Jathal MK, Madhav A, Johnson SD, van Spyk E, Mikhailova M, Zierenberg-Ripoll A, Xue L, Vinall RL, deVere White RW, Ghosh PM. PMID: 21844010; PMCID: PMC3186857.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansAnimalsCells
    56. Dual blockade of PKA and NF-κB inhibits H2 relaxin-mediated castrate-resistant growth of prostate cancer sublines and induces apoptosis. Horm Cancer. 2011 Aug; 2(4):224-38. Vinall RL, Mahaffey CM, Davis RR, Luo Z, Gandour-Edwards R, Ghosh PM, Tepper CG, de Vere White RW. PMID: 21789713; PMCID: PMC3249648.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    57. Targeting ErbB3: the New RTK(id) on the Prostate Cancer Block. Immunol Endocr Metab Agents Med Chem. 2011 Jun; 11(2):131-149. Jathal MK, Chen L, Mudryj M, Ghosh PM. PMID: 21603064; PMCID: PMC3095967.
      View in: PubMed   Mentions: 41  
    58. Statins and prostate cancer: role of cholesterol inhibition vs. prevention of small GTP-binding proteins. Am J Cancer Res. 2011; 1(4):542-61. Roy M, Kung HJ, Ghosh PM. PMID: 21984972; PMCID: PMC3186052.
      View in: PubMed   Mentions: 35  
    59. Androgen Receptor regulation of Vitamin D receptor in response of castration-resistant prostate cancer cells to 1α-Hydroxyvitamin D5 - a calcitriol analog. Genes Cancer. 2010 Nov 16; 1(9):927-940. Mooso B, Madhav A, Johnson S, Roy M, Moore ME, Moy C, Loredo GA, Mehta RG, Vaughan AT, Ghosh PM. PMID: 21552398; PMCID: PMC3089062.
      View in: PubMed   Mentions: 11  
    60. Genome-wide analysis of androgen receptor binding and gene regulation in two CWR22-derived prostate cancer cell lines. Endocr Relat Cancer. 2010 Dec; 17(4):857-73. Chen H, Libertini SJ, George M, Dandekar S, Tepper CG, Al-Bataina B, Kung HJ, Ghosh PM, Mudryj M. PMID: 20634343; PMCID: PMC3539310.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    61. Nrdp1-mediated regulation of ErbB3 expression by the androgen receptor in androgen-dependent but not castrate-resistant prostate cancer cells. Cancer Res. 2010 Jul 15; 70(14):5994-6003. Chen L, Siddiqui S, Bose S, Mooso B, Asuncion A, Bedolla RG, Vinall R, Tepper CG, Gandour-Edwards R, Shi X, Lu XH, Siddiqui J, Chinnaiyan AM, Mehra R, Devere White RW, Carraway KL, Ghosh PM. PMID: 20587519; PMCID: PMC2905475.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansAnimalsCells
    62. Microbead arrays for the analysis of ErbB receptor tyrosine kinase activation and dimerization in breast cancer cells. Assay Drug Dev Technol. 2010 Feb; 8(1):27-36. Khan IH, Zhao J, Ghosh P, Ziman M, Sweeney C, Kung HJ, Luciw PA. PMID: 20035613; PMCID: PMC3196214.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    63. ERK regulates calpain 2-induced androgen receptor proteolysis in CWR22 relapsed prostate tumor cell lines. J Biol Chem. 2010 Jan 22; 285(4):2368-74. Chen H, Libertini SJ, Wang Y, Kung HJ, Ghosh P, Mudryj M. PMID: 19946123; PMCID: PMC2807295.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    64. Nuclear versus cytoplasmic localization of filamin A in prostate cancer: immunohistochemical correlation with metastases. Clin Cancer Res. 2009 Feb 01; 15(3):788-96. Bedolla RG, Wang Y, Asuncion A, Chamie K, Siddiqui S, Mudryj MM, Prihoda TJ, Siddiqui J, Chinnaiyan AM, Mehra R, de Vere White RW, Ghosh PM. PMID: 19188148; PMCID: PMC2666194.
      View in: PubMed   Mentions: 66     Fields:    Translation:HumansCells
    65. The effect of sirolimus on prostate-specific antigen (PSA) levels in male renal transplant recipients without prostate cancer. Am J Transplant. 2008 Dec; 8(12):2668-73. Chamie K, Ghosh PM, Koppie TM, Romero V, Troppmann C, deVere White RW. PMID: 18853950; PMCID: PMC4376320.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansPHPublic Health
    66. Regulation of androgen receptor transcriptional activity by rapamycin in prostate cancer cell proliferation and survival. Oncogene. 2008 Nov 27; 27(56):7106-17. Wang Y, Mikhailova M, Bose S, Pan CX, deVere White RW, Ghosh PM. PMID: 18776922; PMCID: PMC2694040.
      View in: PubMed   Mentions: 54     Fields:    Translation:HumansCells
    67. Reduced expression of epidermal growth factor receptors in rat liver during aging. J Gerontol A Biol Sci Med Sci. 2008 Jul; 63(7):683-92. Kamat A, Ghosh PM, Glover RL, Zhu B, Yeh CK, Choudhury GG, Katz MS. PMID: 18693222; PMCID: PMC5886784.
      View in: PubMed   Mentions: 4     Fields:    Translation:AnimalsCells
    68. AKT regulates androgen receptor-dependent growth and PSA expression in prostate cancer. Adv Exp Med Biol. 2008; 617:397-405. Mikhailova M, Wang Y, Bedolla R, Lu XH, Kreisberg JI, Ghosh PM. PMID: 18497063.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    69. Combination treatment of prostate cancer cell lines with bioactive soy isoflavones and perifosine causes increased growth arrest and/or apoptosis. Clin Cancer Res. 2007 Oct 15; 13(20):6204-16. Vinall RL, Hwa K, Ghosh P, Pan CX, Lara PN, de Vere White RW. PMID: 17947488.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    70. Cross-talk between the androgen receptor and the phosphatidylinositol 3-kinase/Akt pathway in prostate cancer. Curr Cancer Drug Targets. 2007 Sep; 7(6):591-604. Wang Y, Kreisberg JI, Ghosh PM. PMID: 17896924.
      View in: PubMed   Mentions: 69     Fields:    Translation:HumansCells
    71. Determining risk of biochemical recurrence in prostate cancer by immunohistochemical detection of PTEN expression and Akt activation. Clin Cancer Res. 2007 Jul 01; 13(13):3860-7. Bedolla R, Prihoda TJ, Kreisberg JI, Malik SN, Krishnegowda NK, Troyer DA, Ghosh PM. PMID: 17606718.
      View in: PubMed   Mentions: 65     Fields:    Translation:HumansCells
    72. The oncogenic potential of a prostate cancer-derived androgen receptor mutant. Prostate. 2007 May 01; 67(6):591-602. Shi XB, Xue L, Tepper CG, Gandour-Edwards R, Ghosh P, Kung HJ, DeVere White RW. PMID: 17262801.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimalsCells
    73. A 90 kDa fragment of filamin A promotes Casodex-induced growth inhibition in Casodex-resistant androgen receptor positive C4-2 prostate cancer cells. Oncogene. 2007 Sep 06; 26(41):6061-70. Wang Y, Kreisberg JI, Bedolla RG, Mikhailova M, deVere White RW, Ghosh PM. PMID: 17420725.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansCells
    74. Signal transduction pathways in androgen-dependent and -independent prostate cancer cell proliferation. Endocr Relat Cancer. 2005 Mar; 12(1):119-34. Ghosh PM, Malik SN, Bedolla RG, Wang Y, Mikhailova M, Prihoda TJ, Troyer DA, Kreisberg JI. PMID: 15788644.
      View in: PubMed   Mentions: 50     Fields:    Translation:HumansCells
    75. beta-Adrenergic-responsive activation of extracellular signal-regulated protein kinases in salivary cells: role of epidermal growth factor receptor and cAMP. Am J Physiol Cell Physiol. 2005 Jun; 288(6):C1357-66. Yeh CK, Ghosh PM, Dang H, Liu Q, Lin AL, Zhang BX, Katz MS. PMID: 15689414.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    76. Phosphorylation of Akt (Ser473) is an excellent predictor of poor clinical outcome in prostate cancer. Cancer Res. 2004 Aug 01; 64(15):5232-6. Kreisberg JI, Malik SN, Prihoda TJ, Bedolla RG, Troyer DA, Kreisberg S, Ghosh PM. PMID: 15289328.
      View in: PubMed   Mentions: 124     Fields:    Translation:HumansCells
    77. Role of protein kinase C in arginine vasopressin-stimulated ERK and p70S6 kinase phosphorylation. J Cell Biochem. 2004 Apr 15; 91(6):1109-29. Ghosh PM, Bedolla R, Thomas CA, Kreisberg JI. PMID: 15048868.
      View in: PubMed   Mentions: 7     Fields:    Translation:AnimalsCells
    78. Akt in prostate cancer: possible role in androgen-independence. Curr Drug Metab. 2003 Dec; 4(6):487-96. Ghosh PM, Malik S, Bedolla R, Kreisberg JI. PMID: 14683476.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansAnimalsCells
    79. Self-regulation of rat liver GAP junction by phosphorylation. Biochim Biophys Acta. 2002 Aug 31; 1564(2):500-4. Ghosh P, Ghosh S, Das S. PMID: 12175934.
      View in: PubMed   Mentions: 2     Fields:    Translation:AnimalsCells
    80. RhoA-dependent murine prostate cancer cell proliferation and apoptosis: role of protein kinase Czeta. Cancer Res. 2002 May 01; 62(9):2630-6. Ghosh PM, Bedolla R, Mikhailova M, Kreisberg JI. PMID: 11980660.
      View in: PubMed   Mentions: 17     Fields:    Translation:AnimalsCells
    81. Immunohistochemical demonstration of phospho-Akt in high Gleason grade prostate cancer. Clin Cancer Res. 2002 Apr; 8(4):1168-71. Malik SN, Brattain M, Ghosh PM, Troyer DA, Prihoda T, Bedolla R, Kreisberg JI. PMID: 11948129.
      View in: PubMed   Mentions: 112     Fields:    Translation:Humans
    82. Differences in sensitivity of biological functions mediated by epidermal growth factor receptor activation with respect to endogenous and exogenous ligands. J Biol Chem. 2002 Jan 04; 277(1):75-86. Sawhney RS, Zhou GH, Humphrey LE, Ghosh P, Kreisberg JI, Brattain MG. PMID: 11684674.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    83. Arginine vasopressin stimulates mesangial cell proliferation by activating the epidermal growth factor receptor. Am J Physiol Renal Physiol. 2001 Jun; 280(6):F972-9. Ghosh PM, Mikhailova M, Bedolla R, Kreisberg JI. PMID: 11352836.
      View in: PubMed   Mentions: 17     Fields:    Translation:AnimalsCells
    84. Bone morphogenetic protein-2 induces cyclin kinase inhibitor p21 and hypophosphorylation of retinoblastoma protein in estradiol-treated MCF-7 human breast cancer cells. Biochim Biophys Acta. 2000 Jul 21; 1497(2):186-96. Ghosh-Choudhury N, Ghosh-Choudhury G, Celeste A, Ghosh PM, Moyer M, Abboud SL, Kreisberg J. PMID: 10903423.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCells
    85. Effect of cyclin E overexpression on lovastatin-induced G1 arrest and RhoA inactivation in NIH3T3 cells. J Cell Biochem. 1999 Sep 15; 74(4):532-43. Ghosh PM, Moyer ML, Mott GE, Kreisberg JI. PMID: 10440923.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimalsCells
    86. Role of RhoA activation in the growth and morphology of a murine prostate tumor cell line. Oncogene. 1999 Jul 15; 18(28):4120-30. Ghosh PM, Ghosh-Choudhury N, Moyer ML, Mott GE, Thomas CA, Foster BA, Greenberg NM, Kreisberg JI. PMID: 10435593.
      View in: PubMed   Mentions: 23     Fields:    Translation:AnimalsCells
    87. Lovastatin induces apoptosis by inhibiting mitotic and post-mitotic events in cultured mesangial cells. Biochim Biophys Acta. 1997 Oct 30; 1359(1):13-24. Ghosh PM, Mott GE, Ghosh-Choudhury N, Radnik RA, Stapleton ML, Ghidoni JJ, Kreisberg JI. PMID: 9398081.
      View in: PubMed   Mentions: 12     Fields:    Translation:AnimalsCells
    88. Cyclic-AMP deficient MDCK cells form tubules. J Cell Biochem. 1995 Dec; 59(4):453-62. Klebe RJ, Grant A, Grant G, Ghosh P. PMID: 8749715.
      View in: PubMed   Mentions: 5     Fields:    Translation:AnimalsCells
    89. Morphological response of mammalian cells to pulsed ac fields. Bioelectrochemistry. 1994 May 1; 33(2):121-133. Ghosh GP, Keese KC, Giaever GI. .
      View in: Publisher Site   Mentions:
    90. Monitoring electropermeabilization in the plasma membrane of adherent mammalian cells. Biophys J. 1993 May; 64(5):1602-9. Ghosh PM, Keese CR, Giaever I. PMID: 8324195; PMCID: PMC1262488.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    With one click, see people who:

    Mentor

    Offer Student Projects

    Run Clinical Trials

    See more options in the Advanced Search tab

    Paramita's Networks
    Concepts (367)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (43)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UC Davis Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version UCSF-v3.1.0-3-g1ef1264b on PROFILES-PWEB03. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California